Drug Price Transparency: Manufacturers Must Justify Increases
This new law requires drug manufacturers to report and justify significant price increases. The goal is to increase transparency in drug costs, which may help citizens understand why prices are rising and potentially impact their access to and cost of treatment, especially for those in Medicare and Medicaid programs.
Key points
Drug manufacturers must report price increases of 10% over 12 months or 25% over 36 months.
Reports must include detailed information on manufacturing costs, research, marketing, and company profits.
Information on drug price increases will be publicly available, increasing transparency.
Companies failing to report will face high penalties, used to improve drug price information.
Expired
Citizen Poll